Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19853541856external-prioritypatent/DE3541856A1/en
Priority claimed from FI925312Aexternal-prioritypatent/FI925312A/en
Application filed by Hoechst AgfiledCriticalHoechst Ag
Publication of FI934079A0publicationCriticalpatent/FI934079A0/en
Publication of FI934079ApublicationCriticalpatent/FI934079A/en
Publication of FI97239BpublicationCriticalpatent/FI97239B/en
Application grantedgrantedCritical
Publication of FI97239CpublicationCriticalpatent/FI97239C/en
The invention relates to a process for the preparation of a fusion protein with both interleukin-2 and hirudin activity by expressing a gene that codes either the C or N terminus which corresponds substantially with the amino acid sequence of interleucin-2, and which also codes hirudin, in a suitable host cell.
FI934079A1985-11-271993-09-17
Process for producing fusion protein
FI97239C
(en)
PREPARATION OF FUNCTIONAL HUMAN UROKINASE PROTEINS, DNA SEQUENCE CODING FOR A PROTEIN INCLUDING THE ENZYMATIC PART OF HUMAN UROKINASE, REPLICABLE EXPRESSION MEDICINE DRUGS, WHICH MAY BE EXPRESSED, EXPRESSED OR CANCELED TRANSCANE DRUGS, WHICH MAY BE EXPRESSED
ARTIFICIAL GENE ENCODING AUTHENTIC human serum albumin, METHOD FOR PREPARATION THEREOF, RECOMBINANT DNA molecule containing GENE, host organism transformed therewith METHOD FOR PRODUCTION OF AUTHENTIC human serum albumin and pharmaceutical preparation containing BE MADE SERUM ALBUMIN
POLYPEPTIDE PRODUCED MICROBIOLOGICALLY WITH THE PROINSULIN AMINO ACID SEQUENCE OF PRIMATE, DNA AND PLASMIDS THAT CODE FOR THIS SEQUENCE, MICROORGANISMS THAT CONTAIN THIS GENETIC INFORMATION AND PROCESS FOR THEIR PREPARATION.